1. Home
  2. CRAI vs TBPH Comparison

CRAI vs TBPH Comparison

Compare CRAI & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CRA International Inc.

CRAI

CRA International Inc.

HOLD

Current Price

$206.06

Market Cap

1.2B

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.65

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRAI
TBPH
Founded
1965
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
993.7M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CRAI
TBPH
Price
$206.06
$18.65
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$239.00
$27.80
AVG Volume (30 Days)
91.9K
552.8K
Earning Date
10-30-2025
11-10-2025
Dividend Yield
0.94%
N/A
EPS Growth
34.79
N/A
EPS
8.34
0.58
Revenue
$731,055,000.00
$80,327,000.00
Revenue This Year
$10.57
$70.78
Revenue Next Year
$3.66
N/A
P/E Ratio
$25.02
$31.33
Revenue Growth
8.69
27.12
52 Week Low
$152.57
$7.90
52 Week High
$214.66
$20.33

Technical Indicators

Market Signals
Indicator
CRAI
TBPH
Relative Strength Index (RSI) 73.36 58.69
Support Level $196.75 $17.25
Resistance Level $209.88 $18.36
Average True Range (ATR) 6.09 0.74
MACD 2.31 -0.14
Stochastic Oscillator 93.04 59.84

Price Performance

Historical Comparison
CRAI
TBPH

About CRAI CRA International Inc.

CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States, while it also has its presence in United Kingdom and Other Countries.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: